Global Digital Pathology

Global Digital Pathology Market Research Report: Forecast (2022-27)

By Component (Software, Services, Hardware), By Application (Clinical Pathology, Teleconsultation, Molecular Diagnostics, Basic & Applied Research, Drug Development, Others (Training & Education, etc. Read more

  • Healthcare
  • Feb 2022
  • 232
  • HC44018

Market Definition

Digital pathology is a dynamic & image-based environment that enables the gathering, managing, & interpreting of pathology information generated from a digitized glass slide. With the rise in its healthcare applications, such as primary & intraoperative diagnosis, medical student & resident training, diagnostic consultation, clinical research, & tumor boards, the Digital Pathology Market has witnessed considerable expansion in recent years.

Moreover, the surging global prevalence of oncology diseases like breast & testicular cancers, multiple myeloma, etc., has led various industry players to invest in new product developments in the field of pathology. These efforts have been well-supported by various governments worldwide, due to which the digital pathology industry has experienced an uptick in growth historically.

Report Coverage Details
Study Period Historical Data: 2017-20
Base Year: 2021
Forecast Period: 2022-27
CAGR 14%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain, Russia, Rest of Europe
Asia-Pacific:  China, India, Japan, South Korea, Australia, Rest of Asia - Pacifc
South America: Brazil, Argentina, Rest of South America
Middle East & Africa: UAE, Saudi Arabia, South Africa, Turkey, Rest of Middle East & Africa
Key Companies Profiled 3Dhistech Ltd., Apollo Enterprise Imaging Corp, Aurora Interactive Ltd., Koninklijke Philips, Corista Llc, Glencoe Software, Inc., Definiens Ag, F. Hoffmann-La Roche Ltd., Digipath Inc., Huron Technologies International Inc., Indica Labs Inc., Leica Biosystem Inc., Leica Microsystems Gmbh, Ligolab Llc, Mikroscan Technologies Inc. and others
Unit Denominations USD Million/Billion

 

Market Insights

The Global Digital Pathology Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2022-27. The growth of the market attributes primarily to the mounting adoption of digital pathology in medical institutions for disease diagnosis as well as in medical colleges for training-based purposes.

Nowadays, the demand for digital pathology solutions has considerably grown due to the rising number of cases for both Communicable & Non-Communicable diseases (NCDs). In 2021, NCDs accounted for 71% of all global deaths, with more than 15 million people aged between 30-69 years dying from NCDs each year, of which 85% of these premature deaths occur in middle & low-income countries.

Due to a significantly high number of medical cases, healthcare facilities have started adopting digital technologies, which has resulted in the growing demand for digital pathology as one of the key solutions for expediting diagnosis-based operations. Moreover, several major medical colleges & hospitals have adopted digital pathology solutions, which, in turn, has encouraged other medical institutions to adopt similar practices in their respective countries. For instance:

·        In 2021, the UK-based Nottingham University Hospitals NHS Trust (NUH) stated that it would deploy Indica Labs' HALO AP digital pathology software in order to manage & view scanned slides for primary diagnosis, secondary consultations, tumor boards, remote reporting, & multi-disciplinary team meetings.

·        According to the WHO, as of 2021, a total number of NCD-related deaths occurred from Cardiovascular diseases (17.9 million), cancer (9.3 million), respiratory diseases (4.1 million), & diabetes (1.5 million).

The trend shows a high number of NCD cases, which shall surge further with the increasing population & usage of tobacco, coupled with sedentary lifestyles. It, in turn, would provide more opportunities for the adoption of digital pathology solutions in the healthcare sector for easy & timely diagnosis of diseases

Global Digital Pathology Market Research Report: Forecast (2022-27)

Impact of Covid-19 on the Global Digital Pathology Market

In 2020, the Covid-19 pandemic accelerated the growth of Digital Pathology with the increased adoption and training. In addition, the paradigm shifts within the medical facilities to rely on digital solutions for operational activities & reduce physical contact catalyzed the market expansion.

Medical facilities worldwide experienced a massive surge in the number of Covid-19 cases where the healthcare sector was witnessing over-capacity to cater to patients. With the increasing number of cases, many makeshift centers got created. This phenomenon attracted sizeable investments in the healthcare sector and enabled it to adopt digital technologies to reduce the work-related pressure on the overburdened work staff.

Market Segmentation

By Component:

  • Software
  • Services
  • Hardware

Of them all, Hardware-based digital pathology solutions witnessed modest growth in their demand. The surging sales of digital cameras & scanners and communication systems among various end-users like healthcare institutions, pharma & biopharma companies, etc., to transfer taken samples from one place to another without degrading their quality or characteristics has bolstered the demand for hardware-based digital pathology solutions. However, the rapid adoption of cloud infrastructure in the healthcare sector has significantly boosted the demand for software-based digital pathology solutions. For instance:

  • In 2021, Xybion Corporation announced its Pristima XD Digital Pathology software to streamline peer-review workflows of pathologists by providing compliant preclinical Non-Good Laboratory Practices (GLP) animal studies in research & development labs.

Amidst the Covid-19 pandemic, many pathologists started working from home, which augmented the need for adopting digital pathology solutions to reduce the time consumed while physically delivering slides. The healthcare sector is readily adopting digital pathology solutions to reduce the workload & increase efficiency.

  • In 2020, Singapore General Hospital (SGH) and Phillips Health Technologies conducted a joint research activity to assess the rise in work efficiency through digital pathology solutions in a medical facility, which was a 7% surge.

By Species:

  • Human Pathology
  • Veterinary Pathology

Based on species, Human Pathology acquired a dominating share in the Global Digital Pathology Market during 2017-20 due to the early adoption of digital pathology solutions and the ever-growing need for diagnosing chronic diseases. The broadening implications of digital pathology solutions in the healthcare sector have augmented the global market growth since these solutions help reduce costs associated with disease diagnosis and slide shipping to specialists while facilitating enhanced lab productivity by minimizing the time & efforts made by pathologists. For instance:

  • In 2019, Reveal Biosciences launched the imageDx NASH digital assay platform, a cloud-based decision support tool for quantitative NASH data. It enhances project accuracy, reproducibility, and scalability. The platform has been developed in association with a team of US-based liver pathologists to advocate both the pre-clinical & research sectors.

On the other hand, Veterinary Pathology is in its embryonic stage currently. However, it displayed remarkable growth in the previous few years, owing to the shifting emphasis of pathologists towards healthcare automation through various technological integrations, like WSI (Whole-Slide Imaging) scanners in laboratories.

In addition, the early adoption of Digital Pathology in humans, the sheer volume of investments in the healthcare sector, and the rising number of pathology centers with increasing communicable diseases is another reason for the mounting demand for Digital Pathology solutions.

Regional Landscape:

Geographically, the Global Digital pathology Market expands across:

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Of them all, North America grabbed a significant share in the Global Digital Pathology Market during 2017-21, primarily due to high-level investments in the healthcare sector across countries like the US, Canada, & Mexico.

North America has been one of the fastest-growing markets worldwide for digital pathology solutions during the historical period. Several key factors, such as easy availability of digital pathology products, extensive presence of leading industry players, the burgeoning demand for quality diagnostics due to high prevalence of cancer, an increasing number of healthcare IT startups, etc., have well-contributed to the elevating demand for digital pathology solutions across the region.

Due to the high prevalence of cancer across North America, pathologists require data to ease personalized therapy for patients. As a result, they are gradually shifting toward adopting digital pathology solutions, owing to their several benefits like accelerated diagnostic accuracy, diagnosis rate, & therapeutic recommendations to improve patient upshots. For instance:

  • In 2020, Unity Biotechnology, a California-based startup, deployed Proscia’s Concentric Digital Pathology software to catalyze its lengthy R&D related to the drug development process by centralizing digital workflows & carrying out image analysis. Moreover, the introduction of favorable reimbursement policies and the implementation of various initiatives by the government in countries like the US & Canada have further stimulated the market growth across North America.

Based on species, Veterinary Pathology is gaining modest traction in the North America Digital Pathology Market. The emerging need for disease diagnostics for vets, the early adoption of veterinary pathology in countries like the US & Canada, and extensive research & development in healthcare have magnified the demand for digital pathology solutions across the region. In addition, the growing count of startups receiving funding for promoting veterinary pathology would also channelize the growth for digital pathology in the years to come. For instance:

  • In 2021, Techcyte received funding worth USD 21 for its digital clinical pathology platform. Zoetis, an animal healthcare company & drugmaker, coupled with ARUP Laboratories, were also involved in the funding process. The company cited that the funding would be used for expanding its vet segment & speeding up commercialization in the pathology market.

Biotech & pharma firms are likely to witness major demand for digital pathology solutions in the coming years, owing to the well-established pharmaceutical & biotechnology industry in North America. These entities conduct extensive research, which, in turn, generates a vast amount of data to be transmitted, wherein digital pathology solutions play a crucial role in streamlining the overall process.

Moreover, the adoption of digital pathology has eliminated the need for a manual sample collection process, owing to which biotech & pharma companies have been the key end-users of digital pathology solutions in the recent past. To promote growth in the region, various players have formed strategic partnerships to leverage the potential of digital pathology, i.e., anticipated to fuel the market growth in the coming years. For instance:

  • In 2021, Roche & PathAI announced a strategic partnership to co-develop and distribute digital pathology diagnostics by making an embedded image analysis workflow for pathologists.

Based on components, North America is likely to observe a significant demand uptrend for Digital Pathology software in the forthcoming years, owing to the extensive presence of world-class software companies in the region, especially in the US, and various toward healthcare automation by the regional governments. For instance:

  • In 2021, Roche launched the Digital Pathology Open Environment to encourage collaboration among software developers to improve patient outcomes & extend personalized healthcare through innovative image analysis tools for tumor tissues.

Based on application, the demand for Digital Pathology solutions in the Teleconsultation application is expected to witness sustainable growth across North America over the forecast years. It owes to its crucial role in obliterating the need for pathologists to carry samples to hospitals or clinics. In case of a medical emergency, teleconsultation proves to be a lifesaver. For instance:

  • OptraSCAN Inc, a US-based medical equipment manufacturer, provides OS-FS Frozen Sections Scanner in the surgical suite that allows the specimen to be viewed remotely using OptraSCAN Live View Mode from anywhere around the world.

With the advent of the Covid-19 pandemic, digital pathology solutions for teleconsultation have witnessed an increased demand since there was a dire need for healthcare professionals to communicate with each other owing to strict mobility restrictions imposed across North American countries. Hence, owing to these aspects, the Digital Pathology Market in North America has witnessed the fastest growth in the previous few years.

The US Remained the Global Dominant Force

During 2017-20, the Digital Pathology Market in the US experienced significant growth opportunities due to the extensive healthcare R&D capabilities and an expanding network of end-users, including biotech companies, hospitals, academic & research institutes, etc., in the country, which use digital pathology solutions. The US has a widely scattered, highly sophisticated, and complex healthcare system due to which there are burgeoning workloads in clinical laboratories.

The deployment of digital pathology helps healthcare professionals access a broader range of databases and simultaneously reduce costs & time. Despite the growing uptrend, the country faces several setbacks due to the strict regulations imposed by various institutions associated with digital pathology, which has withheld the demand to some extent. For instance:

  • The Health Insurance Portability and Accountability Act (HIPAA) Act, 1996, which focuses on the concept of Protected Health Information (PHI), imposes some security & privacy requirements for digital pathology systems in the US.

Market Dynamics:

Key Driver: Increasing Prevalence of Oncology Disorders

Oncology disorders are considered the most common premature mortality worldwide. The increasing number of cancer patients has infused the demand for digital pathology solutions since they help pathologists streamline diagnostic workflows in oncology disorders. According to GLOBOCAN, the Global Cancer Observatory, an estimated 28.4 million new cancer cases are likely by 2040 worldwide, i.e., a 47% increase from the estimated 19.3 million cases in 2020. Besides, the surging incidence of oncology disorders across regions like Australia, New Zealand, North America, Europe, etc., is another crucial aspect projected to drive the Global Digital Pathology Market over the forecast years.

Possible Challenge: Lack of Skilled Pathologists

The lack of trained or skilled pathologists poses a prominent challenge to the Digital Pathology Market. The shortage of qualified pathologists, especially across Asia-Pacific & Africa, is creating distress in the market, mainly due to the rising adoption of digital pathology solutions in these regions for remote pathological services in rural areas, coupled with the burgeoning incidences of oncology disorders.

Key Questions Answered in the Market Research Report:

  1. What are the overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares) of the Global Digital Pathology Market?
  2. What is the region-wise industry size, growth drivers, and challenges?
  3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Digital Pathology Market?
  4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Digital Pathology Market based on a competitive benchmarking matrix?
  5. What are the key results derived from surveys conducted during the Global Digital Pathology Market study?  

Frequently Asked Questions

A. The Global Digital Pathology Market is projected to grow at a CAGR of around 14% during 2022-27.

A. Asia Pacific, followed by North America & Europe are anticipated to emerge as an area of remunerative growth opportunities for the leading players in the Global Digital Pathology Market during 2022-27.

A. The growing adoption of advanced technologies by the healthcare sector across the middle-income countries with the high number of cases for mon-communicable diseases is one of the prime aspects anticipated to drive the Global Digital Pathology Market during 2022-27.

A. With the aftermath of over capacitating healthcare sector amidst the Covid-19 pandemic in 2020 and unforeseen surge in the adoption of digital technologies in the healthcare sector, the demand for digital pathology solutions would decently grow in the coming years.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Market Segmentation
    4. Assumptions
  2. Preface
  3. Executive Summary
  4. Global Digital Pathology Market Start-up Ecosystem
    1. Entrepreneurial Activity
    2. Year on Year Funding Received
    3. Funding Received by Top Companies
    4. Key Investors Active in the Market
    5. Series Wise Funding Received
      1. Seed Funding
      2. Angel Investing
      3. Venture Capitalists (VC) Funding
      4. Others
  5. Global Digital Pathology Market Technology Integration
    1. Artificial Intelligence
    2. Analytics
    3. Digital Transformation
    4. Others
  6. Global Digital Pathology Market Business Cases
  7. Impact of COVID-19 on Global Digital Pathology Market
  8. Global Digital Pathology Market Trends & Insights
  9. Global Digital Pathology Market Dynamics
    1. Drivers
    2. Challenges
  10. Global Digital Pathology Market Regulations, Policies & Standards, By region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia Pacific 
  11. Global Digital Pathology Market Supply Chain Analysis
  12. Global Digital Pathology Market Hotspots & Opportunities
  13. Global Digital Pathology Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Component
        1. Software
        2. Services
        3. Hardware
          1. Digital Camera & Scanners
          2. Communication Systems
          3. Storage Systems
          4. Others (Information Management Systems, robotic microscopes, other diagnostic devices, etc.)
      2. By Application
        1. Clinical Pathology
        2. Teleconsultation
        3. Molecular Diagnostics
        4. Basic & Applied Research
        5. Drug Development
        6. Others (Training & Education, etc.)
      3. By Species
        1. Human Pathology
        2. Veterinary Pathology
      4. By Type
        1. Genetic Pathology
        2. Hematology and Clinical Pathology
        3. Immunopathology
        4. Chemical Pathology
        5. Forensic Pathology
        6. Microbiology
      5. By End Users
        1. Biotech and Pharma Companies
        2. Healthcare Service Providers
        3. Educational Institutes
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
      7. By Company
        1. Competition Characteristics
        2. Market Share of Leading Companies, By Revenues
  14. North America Digital Pathology Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Species
      4. By Type
      5. By End User
      6. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. Canada Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    5. Mexico Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
  15. South America Digital Pathology Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Species
      4. By Type
      5. By End User
      6. By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    3. Brazil Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. Argentina Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
  16. Europe Digital Pathology Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Species
      4. By Type
      5. By End User
      6. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. Germany Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. The UK Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    5. France Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    6. Italy Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    7. Spain Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
  17. Middle East & Africa Digital Pathology Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Species
      4. By Type
      5. By End User
      6. By Country
        1. Saudi Arabia
        2. UAE
        3. Turkey
        4. South Africa
        5. Rest of Middle East & Africa
    3. Saud Arabia Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. UAE Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    5. Turkey Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    6. South Africa Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
  18. Asia Pacific Digital Pathology Market Outlook, 2017-2027
    1. Market Size & Analysis
      1. By Revenues (USD Billion)
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Species
      4. By Type
      5. By End User
      6. By Country
        1. China
        2. Japan
        3. India
        4. South Korea
        5. Australia
        6. Rest of Asia Pacific
    3. China Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. Japan Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    5. India Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    6. South Korea Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
    7. Australia Digital Pathology Market Outlook, 2017-2027
      1. Market Size & Analysis
        1. By Revenues (USD Billion)
      2. Market Share & Analysis
        1. By Component
        2. By Application
  19. Global Digital Pathology Market Key Strategic Imperatives for Growth & Success
  20. Competition Outlook
    1. Competition Matrix
      1. Brand Specialization
      2. Target Markets
      3. Target End Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles
      1. 3Dhistech Ltd.
      2. Apollo Enterprise Imaging Corp
      3. Aurora Interactive Ltd.
      4. Koninklijke Philips
      5. Corista Llc
      6. Glencoe Software, Inc.
      7. Definiens Ag
      8. F. Hoffmann-La Roche Ltd.
      9. Digipath Inc.
      10. Huron Technologies International Inc.
      11. Indica Labs Inc.
      12. Leica Biosystem Inc.
      13. Leica Microsystems Gmbh
      14. Ligolab Llc
      15. Mikroscan Technologies Inc.
      16. Others
        1. Nikon Instruments Inc.
        2. Omnyx Llc
        3. Pathcentral Inc.
        4. Pathxl
        5. Pixcelldata Ltd.
        6. Sunquest Information Systems
        7. Ventana Medical Systems Inc.
        8. Visiopharm
        9. Xifin
        10. Others
  21. Disclaimer
Digital Pathology Market Segmentation